Aktionsplan Shin Nippon Biomedical Laboratories, Ltd.
Über das Unternehmen Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd., контрактная исследовательская организация, предоставляет услуги по открытию и разработке лекарств в Японии и за рубежом. Он предлагает доклинические лабораторные услуги, такие как проверки надлежащей лабораторной практики; исследования общей и специфической токсичности; патологоанатомические исследования; ПК/ФД биофармацевтических препаратов, тесты на иммунотоксичность и производство антител; исследования репродуктивной токсичности и токсичности для развития; фармакология и исследования фармакологической эффективности; и услуги визуализации. weitere detailsДив.доход ао | 5.72 |
---|---|
Дивиденд ао | 50 |
Сайт | https://www.snbl.co.jp |
Цена ао | 1669 |
Preisänderung pro Tag: | +2.64% (1669) |
---|---|
Preisänderung pro Woche: | +3.25% (1659) |
Preisänderung pro Monat: | +8.35% (1581) |
Preisänderung über 3 Monate: | +40.18% (1222) |
Preisänderung über sechs Monate: | +28.99% (1328) |
Preisänderung pro Jahr: | -8.98% (1882) |
Preisänderung seit Jahresbeginn: | +7.47% (1594) |
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
Institutionen | Volumen | Aktie, % |
---|---|---|
Vanguard International Stock Index-Total Intl Stock Indx | 267904 | 0.64 |
Principal International Small Company Fd | 149700 | 0.36 |
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 148621 | 0.36 |
DFA Japanese Small Company Series | 134300 | 0.32 |
iShares Core MSCI EAFE ETF | 118300 | 0.28 |
DFA International Core Equity Portfolio | 103700 | 0.25 |
iShares MSCI EAFE Small Cap ETF | 83400 | 0.2 |
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 71400 | 0.17 |
iShares International Small-Cap Equity Factor ETF | 68400 | 0.16 |
WisdomTree Tr-WisdomTree Japan Hedged Equity Fd | 43000 | 0.1 |
Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
---|---|---|---|
Dr. Ryoichi Nagata F.F.P.M., M.D., Ph.D. | Chairman, CEO, President, Head of Fisheries Business & CHO | 144.06M | 1958 (67 Jahre) |
Fumihiko Makino | Senior Executive Officer, Financial Controller and GM of Finance & Accounting | N/A | |
Toshiyuki Iwata | Managing Executive Officer and GM of IR Public Relations Department & Sustainability | N/A | |
Shinji Nitanda | Senior MD of Corporate Development & Corporate Tax Administration and Director | N/A | 1968 (57 Jahre) |
Kyomi Nagatoshi | Managing Executive Officer, Head of General Affairs & Human Resources and Director | N/A | |
Mr. Ken Takanashi CPA, MBA. | Executive VP of Group Corporate Management & Global Business & Director | N/A | 1964 (61 Jahr) |
Dr. Hideshi Tsusaki DVM Ph.D. | Senior MD, President of Non-Clinical & Global Business Development and Director | N/A | 1967 (58 Jahre) |
Terumasa Hirai | Managing Executive Officer, Preclinical Company VP & Director of Safety Research Institute | N/A | |
Mr. Ichiro Nagata | Executive VP, Head of CRO Business, Head of Hospitality Business & Director | N/A | 1985 (40 Jahre) |
Mr. Eishi Tsunozaki | Senior MD & Director | N/A | 1967 (58 Jahre) |
Adresse: Japan, Tokyo -, St. Luke’s Tower - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.snbl.co.jp
Webseite: https://www.snbl.co.jp